1. Home
  2. ALTI vs ALT Comparison

ALTI vs ALT Comparison

Compare ALTI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • ALT
  • Stock Information
  • Founded
  • ALTI 2020
  • ALT 1997
  • Country
  • ALTI United States
  • ALT United States
  • Employees
  • ALTI N/A
  • ALT N/A
  • Industry
  • ALTI Investment Managers
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTI Finance
  • ALT Health Care
  • Exchange
  • ALTI Nasdaq
  • ALT Nasdaq
  • Market Cap
  • ALTI 388.9M
  • ALT 348.6M
  • IPO Year
  • ALTI N/A
  • ALT N/A
  • Fundamental
  • Price
  • ALTI $3.89
  • ALT $4.00
  • Analyst Decision
  • ALTI
  • ALT Strong Buy
  • Analyst Count
  • ALTI 0
  • ALT 7
  • Target Price
  • ALTI N/A
  • ALT $16.50
  • AVG Volume (30 Days)
  • ALTI 100.4K
  • ALT 2.7M
  • Earning Date
  • ALTI 11-10-2025
  • ALT 11-07-2025
  • Dividend Yield
  • ALTI N/A
  • ALT N/A
  • EPS Growth
  • ALTI N/A
  • ALT N/A
  • EPS
  • ALTI N/A
  • ALT N/A
  • Revenue
  • ALTI $217,760,000.00
  • ALT $20,000.00
  • Revenue This Year
  • ALTI $19.78
  • ALT N/A
  • Revenue Next Year
  • ALTI $7.00
  • ALT N/A
  • P/E Ratio
  • ALTI N/A
  • ALT N/A
  • Revenue Growth
  • ALTI N/A
  • ALT N/A
  • 52 Week Low
  • ALTI $2.33
  • ALT $2.90
  • 52 Week High
  • ALTI $5.00
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 57.69
  • ALT 54.65
  • Support Level
  • ALTI $3.74
  • ALT $3.83
  • Resistance Level
  • ALTI $4.02
  • ALT $4.15
  • Average True Range (ATR)
  • ALTI 0.14
  • ALT 0.16
  • MACD
  • ALTI 0.04
  • ALT 0.01
  • Stochastic Oscillator
  • ALTI 88.71
  • ALT 70.30

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: